Larimar Therapeutics, Inc. (LRMR)
NASDAQ·Healthcare·Biotechnology
$4.38
-1.46%
Mkt Cap $388.52M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 19, 2026 | — | — | — | -$0.44 | -$0.73 | -65.91% | — | — |
| Q4 2025 Nov 5, 2025 | — | — | — | -$0.39 | -$0.61 | -56.41% | — | — |
| Q3 2025 Aug 14, 2025 | — | — | — | -$0.47 | -$0.41 | +12.77% | — | — |
| Q2 2025 Apr 30, 2025 | — | — | — | -$0.42 | -$0.46 | -9.52% | — | — |
| Q1 2025 Mar 24, 2025 | — | $241.00K | — | -$0.29 | -$0.45 | -55.17% | — | — |
| Q4 2024 Oct 30, 2024 | — | — | — | -$0.37 | -$0.24 | +35.14% | — | — |
| Q3 2024 Aug 7, 2024 | — | — | — | -$0.32 | -$0.34 | -6.25% | — | — |
| Q2 2024 May 9, 2024 | — | — | — | -$0.24 | -$0.27 | -12.50% | — | — |
| Q1 2024 Mar 14, 2024 | — | — | — | -$0.25 | -$0.30 | -20.00% | — | — |
| Q4 2023 Nov 14, 2023 | — | — | — | -$0.23 | -$0.21 | +8.70% | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | -$0.21 | -$0.19 | +9.52% | — | — |
| Q2 2023 May 15, 2023 | — | — | — | -$0.25 | -$0.15 | +40.00% | — | — |
| Q1 2023 Mar 14, 2023 | — | — | — | -$0.78 | -$0.21 | +73.08% | — | — |
| Q4 2022 Nov 10, 2022 | — | — | — | -$0.50 | -$0.37 | +26.00% | — | — |
| Q3 2022 Aug 11, 2022 | — | — | — | -$0.62 | -$0.47 | +24.19% | — | — |
| Q2 2022 May 12, 2022 | — | — | — | -$0.62 | -$0.49 | +20.97% | — | — |
| Q1 2022 Mar 25, 2022 | — | — | — | -$0.72 | -$0.50 | +30.56% | — | — |
| Q4 2021 Nov 12, 2021 | — | — | — | -$0.62 | -$0.92 | -48.39% | — | — |
| Q3 2021 Aug 12, 2021 | — | — | — | -$0.73 | -$0.79 | -8.22% | — | — |
| Q2 2021 May 10, 2021 | — | — | — | -$0.93 | -$0.76 | +18.28% | — | — |